Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1986Clinical Endocrinology

Loss of Luteinizing Hormone Bioactivity in Patients With Prostatic Cancer Treated With an LHRH Agonist and a Pure Antiandrogen

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRené St‐ArnaudShriners Hospitals for Children - CanadaRLRoger LachanceUniversité LavalSKSusan J. KellyDuke University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

St‐Arnaud et al. (1986) studied this question.

synapsesocial.com/papers/6a7d233bb97b7d2d4f83d986https://doi.org/10.1111/j.1365-2265.1986.tb03250.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Important Advances in Oncology: 19861986 · 909 citations
  2. 2A Comparison of Bioactivity and Immunoactivity of Luteinizing Hormone Stored in and Released inVitrofrom Pituitary Glands of Rats under Various Gonadal States*1979 · 42 citations
  3. 3Properties of the phosphorylated beta subunit of human choriogonadotropin.1983 · 20 citations
  4. 4In<i>Vitro</i>Bioassay of LH in Human Serum: The Rat Interstitial Cell Testosterone (RICT) Assay1976 · 175 citations
  5. 5Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.1983 · 105 citations